1	Abbott	abbott	NNP	_	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	expanded	expand	VBN	pb=expand.01	0	root	_
4	its	its	PRP$	_	5	poss	_
5	presence	presence	NN	_	3	dobj	3:A1=PPT
6	in	in	IN	_	3	prep	3:AM-LOC
7	the	the	DT	_	10	det	_
8	Latin	latin	JJ	_	9	amod	_
9	American	american	JJ	_	10	amod	_
10	region	region	NN	_	6	pobj	_
11	with	with	IN	_	10	prep	_
12	the	the	DT	_	13	det	_
13	purchase	purchase	NN	_	11	pobj	_
14	of	of	IN	_	13	prep	_
15	CFR	cfr	NNP	_	16	nn	_
16	Pharmaceuticals	pharmaceutical	NNPS	p2=NNP	14	pobj	_
17	and	and	CC	_	16	cc	_
18	its	its	PRP$	_	19	poss	_
19	portfolio	portfolio	NN	_	16	conj	_
20	of	of	IN	_	19	prep	_
21	generic	generic	JJ	_	22	amod	_
22	medicines	medicine	NNS	_	20	pobj	_
23	.	.	.	_	3	punct	_

1	Abbott	abbott	NNP	_	16	nsubj	4:A0=PAG;16:A0=PAG
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	4	nsubj	4:R-A0
4	spun	spin	VBD	pb=spin.02	1	rcmod	_
5	out	out	RP	_	4	prt	4:C-V
6	its	its	PRP$	_	9	poss	_
7	research-focused	research-focused	JJ	p2=VBD	9	amod	_
8	pharma	pharma	NN	_	9	nn	_
9	division	division	NN	_	4	dobj	4:A1=PPT
10	as	as	IN	p2=RB	4	prep	4:AM-TMP
11	AbbVie	abbvie	NNP	_	10	pobj	_
12	last	last	JJ	_	13	amod	_
13	year	year	NN	_	4	npadvmod	4:AM-TMP
14	,	,	,	_	1	punct	_
15	will	will	MD	_	16	aux	16:AM-MOD
16	pay	pay	VB	pb=pay.01	0	root	_
17	a	a	DT	_	18	det	_
18	total	total	NN	_	16	dobj	16:A1=VSP
19	of	of	IN	_	18	prep	_
20	$	$	$	p2=,	21	nmod	_
21	3.33bn	0bn	CD	p2=NNP	19	pobj	_
22	for	for	IN	_	21	prep	_
23	Chile	chile	NNP	_	25	hmod	_
24	-	-	HYPH	_	25	hyph	_
25	based	base	VBN	_	26	amod	_
26	CFR	cfr	NNP	p2=NN	22	pobj	_
27	,	,	,	_	16	punct	_
28	comprising	comprise	VBG	pb=comprise.01	16	advcl	16:AM-ADV
29	a	a	DT	_	31	det	_
30	purchase	purchase	NN	_	31	nn	_
31	price	price	NN	_	28	dobj	28:A1=PPT
32	of	of	IN	_	31	prep	_
33	$	$	$	p2=NFP	34	nmod	_
34	2.9bn	0bn	CD	p2=NNP	32	pobj	_
35	and	and	CC	_	31	cc	_
36	the	the	DT	_	37	det	_
37	assumption	assumption	NN	_	31	conj	_
38	of	of	IN	_	37	prep	_
39	net	net	JJ	_	40	amod	_
40	debt	debt	NN	_	38	pobj	_
41	of	of	IN	_	40	prep	_
42	$	$	$	p2=VBG	43	nmod	_
43	430m	0m	CD	_	41	pobj	_
44	.	.	.	_	16	punct	_

1	The	the	DT	_	2	det	_
2	deal	deal	NN	_	5	nsubj	_
3	more	more	JJR	p2=RBR	2	amod	_
4	than	than	IN	_	3	advmod	_
5	doubles	double	VBZ	pb=double.01	0	root	_
6	Abbott	abbott	NNP	_	8	poss	_
7	's	's	POS	_	6	possessive	_
8	presence	presence	NN	_	5	dobj	5:A1=PPT
9	in	in	IN	_	8	prep	_
10	Latin	latin	NNP	_	11	nn	_
11	America	america	NNP	_	9	pobj	_
12	and	and	CC	_	5	cc	_
13	makes	make	VBZ	pb=make.02	5	conj	_
14	the	the	DT	_	15	det	_
15	company	company	NN	_	13	dobj	13:A1=PRD
16	among	among	IN	_	13	prep	13:AM-LOC
17	the	the	DT	_	21	det	_
18	top	top	JJ	p2=NN	21	amod	_
19	10	0	CD	_	21	num	_
20	pharma	pharma	NN	p2=JJ	21	nn	_
21	firms	firm	NNS	_	16	pobj	_
22	in	in	IN	_	21	prep	_
23	the	the	DT	_	24	det	_
24	region	region	NN	_	22	pobj	_
25	.	.	.	_	5	punct	_

1	It	it	PRP	_	2	nsubj	2:A1=PPT
2	is	be	VBZ	pb=be.01	0	root	_
3	a	a	DT	_	4	det	_
4	region	region	NN	_	2	attr	7:A1=PPT;2:A2=PRD
5	that	that	WDT	_	7	nsubj	7:R-A1
6	is	be	VBZ	_	7	aux	_
7	growing	grow	VBG	pb=grow.01	4	rcmod	_
8	in	in	IN	p2=RP	7	prep	7:AM-LOC
9	significance	significance	NN	_	8	pobj	_
10	for	for	IN	_	9	prep	_
11	the	the	DT	_	12	det	_
12	industry	industry	NN	_	10	pobj	_
13	,	,	,	_	12	punct	_
14	with	with	IN	_	12	prep	_
15	the	the	DT	_	16	det	_
16	market	market	NN	_	14	pobj	_
17	for	for	IN	_	16	prep	_
18	pharmaceutical	pharmaceutical	JJ	_	19	amod	_
19	products	product	NNS	_	17	pobj	23:A1=PPT;25:A1=PPT
20	in	in	IN	_	19	prep	_
21	Latin	latin	NNP	p2=JJ	22	nn	_
22	America	america	NNP	_	20	pobj	_
23	set	set	VBN	p2=VBD|pb=set.08	19	partmod	_
24	to	to	TO	_	25	aux	_
25	grow	grow	VB	pb=grow.01	23	xcomp	23:A2=PRD
26	in	in	IN	_	25	prep	25:AM-MNR
27	value	value	NN	_	26	pobj	_
28	from	from	IN	_	25	prep	25:A3=DIR
29	$	$	$	p2=NNP	30	nmod	_
30	73bn	0bn	CD	p2=NNP	28	pobj	_
31	in	in	IN	_	28	prep	_
32	2014	0	CD	_	31	pobj	_
33	to	to	IN	p2=TO	28	prep	_
34	$	$	$	p2=CD	35	nmod	_
35	124bn	0bn	CD	p2=VBN	33	pobj	_
36	by	by	IN	_	35	prep	_
37	2018	0	CD	_	36	pobj	_
38	.	.	.	_	2	punct	_

1	With	with	IN	_	9	prep	9:AM-MNR
2	the	the	DT	_	3	det	_
3	purchase	purchase	NN	_	1	pobj	_
4	of	of	IN	_	3	prep	_
5	CFR	cfr	NNP	p2=NN	4	pobj	_
6	,	,	,	_	9	punct	_
7	Abbott	abbott	NNP	_	9	nsubj	9:A0=PAG
8	will	will	MD	_	9	aux	9:AM-MOD
9	add	add	VB	pb=add.02	0	root	_
10	a	a	DT	_	11	det	_
11	portfolio	portfolio	NN	_	9	dobj	9:A1=PPT
12	of	of	IN	_	11	prep	_
13	generic	generic	JJ	_	14	amod	_
14	products	product	NNS	_	12	pobj	15:A2
15	covering	cover	VBG	pb=cover.01	14	partmod	_
16	women	woman	NNS	_	18	poss	_
17	's	's	POS	_	16	possessive	_
18	health	health	NN	_	15	dobj	15:A1=PPT
19	,	,	,	_	18	punct	_
20	infectious	infectious	JJ	_	21	amod	_
21	diseases	disease	NNS	_	18	conj	_
22	,	,	,	_	21	punct	_
23	skincare	skincare	NN	p2=JJ	21	conj	_
24	and	and	CC	_	23	cc	_
25	more	more	JJR	p2=RBR	23	conj	_
26	.	.	.	_	9	punct	_

1	These	these	DT	_	2	det	_
2	products	product	NNS	_	5	nsubjpass	5:A1=PPT
3	are	be	VBP	_	5	auxpass	_
4	currently	currently	RB	_	5	advmod	5:AM-TMP
5	marketed	market	VBN	pb=market.01	0	root	_
6	by	by	IN	_	5	agent	5:A0=PAG
7	CFR	cfr	NNP	_	6	pobj	_
8	in	in	IN	_	5	prep	5:AM-LOC
9	15	0	CD	_	10	num	_
10	regions	region	NNS	_	8	pobj	15:A1=PPT
11	in	in	IN	_	10	prep	_
12	Latin	latin	NNP	_	13	nn	_
13	America	america	NNP	_	11	pobj	_
14	,	,	,	_	10	punct	_
15	led	lead	VBN	pb=lead.02	10	partmod	_
16	by	by	IN	_	15	agent	15:A0=PAG
17	Chile	chile	NNP	_	16	pobj	_
18	,	,	,	_	17	punct	_
19	Peru	peru	NNP	_	17	conj	_
20	,	,	,	_	19	punct	_
21	Argentina	argentina	NNP	_	19	conj	_
22	and	and	CC	_	21	cc	_
23	Columbia	columbia	NNP	_	21	conj	_
24	.	.	.	_	5	punct	_

1	Abbott	abbott	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	it	it	PRP	_	4	nsubj	4:A0
4	expects	expect	VBZ	pb=expect.01	2	ccomp	2:A1=PPT
5	the	the	DT	_	6	det	_
6	acquisition	acquisition	NN	_	8	nsubj	8:A0=PAG;23:A0=PAG
7	to	to	TO	_	8	aux	_
8	add	add	VB	pb=add.02	4	ccomp	4:A1=PPT
9	$	$	$	_	10	nmod	_
10	900	0	CD	_	11	nn	_
11	m	m	NN	p2=TO	8	dobj	8:A1=PPT
12	to	to	IN	_	8	prep	8:A2=PPT
13	its	its	PRP$	_	14	poss	_
14	sales	sale	NNS	_	12	pobj	_
15	in	in	IN	_	8	prep	8:AM-TMP
16	the	the	DT	_	19	det	_
17	first	#ord#	JJ	_	19	amod	_
18	full	full	JJ	_	19	amod	_
19	year	year	NN	_	15	pobj	_
20	after	after	IN	_	19	prep	_
21	completion	completion	NN	_	20	pobj	_
22	and	and	CC	_	8	cc	_
23	help	help	VB	p2=VBP|pb=help.01	8	conj	_
24	it	it	PRP	_	25	nsubj	25:A0=PAG
25	achieve	achieve	VB	pb=achieve.01	23	ccomp	23:A1=PPT
26	double	double	JJ	_	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	digit	digit	NN	_	29	nn	_
29	sales	sale	NNS	_	30	nn	_
30	growth	growth	NN	_	25	dobj	25:A1=PPT
31	over	over	IN	_	25	prep	25:AM-TMP
32	the	the	DT	_	35	det	_
33	next	next	JJ	_	35	amod	_
34	several	several	JJ	_	35	amod	_
35	years	year	NNS	_	31	pobj	_
36	,	,	,	_	23	punct	_
37	thanks	thanks	NNS	_	23	npadvmod	_
38	to	to	IN	_	37	prep	_
39	strong	strong	JJ	_	40	amod	_
40	growth	growth	NN	_	38	pobj	_
41	at	at	IN	_	40	prep	_
42	CFR	cfr	NNP	_	41	pobj	_
43	,	,	,	_	40	punct	_
44	whose	whose	WP$	_	46	poss	_
45	annual	annual	JJ	_	46	amod	_
46	revenues	revenue	NNS	_	47	nsubj	47:R-A1
47	climbed	climb	VBD	pb=climb.02	23	ccomp	_
48	from	from	IN	_	47	prep	47:A3=DIR
49	$	$	$	_	51	quantmod	_
50	490	0	CD	_	51	number	_
51	m	m	CD	p2=NN	48	pobj	_
52	in	in	IN	_	47	prep	47:AM-TMP
53	2011	0	CD	_	52	pobj	_
54	to	to	IN	p2=TO	47	prep	47:A4=GOL
55	$	$	$	_	57	quantmod	_
56	767	0	CD	_	57	number	_
57	m	m	CD	p2=NN	54	pobj	_
58	in	in	IN	_	47	prep	47:AM-TMP
59	2013	0	CD	_	58	pobj	_
60	.	.	.	_	2	punct	_

1	Miles	miles	NNP	_	2	nn	_
2	White	white	NNP	_	12	nsubj	12:A0
3	,	,	,	_	2	punct	_
4	chairman	chairman	NN	_	2	appos	_
5	and	and	CC	_	4	cc	_
6	chief	chief	JJ	_	8	amod	_
7	executive	executive	JJ	_	8	amod	_
8	officer	officer	NN	_	4	conj	_
9	at	at	IN	_	4	prep	_
10	Abbott	abbott	NNP	_	9	pobj	_
11	,	,	,	_	2	punct	_
12	said	say	VBD	pb=say.01	0	root	_
13	:	:	:	_	12	punct	_
14	"	"	``	_	12	punct	_
15	This	this	DT	_	16	det	_
16	acquisition	acquisition	NN	_	19	nsubj	19:A0=PAG;21:A0=PAG;31:A1=PPT
17	will	will	MD	_	19	aux	19:AM-MOD;21:AM-MOD
18	significantly	significantly	RB	_	19	advmod	19:AM-MNR;21:AM-MNR
19	enhance	enhance	VB	pb=enhance.01	12	ccomp	12:A1=PPT
20	and	and	CC	_	19	cc	_
21	broaden	broaden	VB	pb=broaden.01	19	conj	_
22	Abbott	abbott	NNP	_	26	poss	_
23	's	's	POS	_	22	possessive	_
24	Latin	latin	JJ	p2=NNP	25	amod	_
25	American	american	JJ	p2=NNP	26	amod	_
26	footprint	footprint	NN	_	21	dobj	21:A1=PPT
27	,	,	,	_	19	punct	_
28	and	and	CC	_	19	cc	_
29	is	be	VBZ	_	31	auxpass	_
30	well	well	RB	p2=UH	31	advmod	31:AM-MNR
31	aligned	align	VBN	p2=JJ|pb=align.01	19	conj	_
32	with	with	IN	_	31	prep	31:A2
33	our	our	PRP$	_	37	poss	_
34	long	long	JJ	_	36	hmod	_
35	-	-	HYPH	_	36	hyph	_
36	term	term	NN	_	37	nn	_
37	strategy	strategy	NN	_	32	pobj	_
38	and	and	CC	_	37	cc	_
39	commitment	commitment	NN	_	37	conj	_
40	to	to	IN	_	39	prep	_
41	fast	fast	RB	_	43	hmod	_
42	-	-	HYPH	_	43	hyph	_
43	growing	grow	VBG	_	44	amod	_
44	markets	market	NNS	_	40	pobj	_
45	.	.	.	_	12	punct	_
46	"	"	''	_	12	punct	_

1	In	in	IN	_	13	prep	13:AM-DIS
2	addition	addition	NN	_	1	pobj	_
3	to	to	IN	_	2	prep	_
4	acquiring	acquire	VBG	pb=acquire.01	3	pcomp	_
5	CFR	cfr	NNP	_	8	poss	_
6	's	's	POS	_	5	possessive	_
7	product	product	NN	_	8	nn	_
8	portfolio	portfolio	NN	_	4	dobj	4:A1=PPT
9	,	,	,	_	13	punct	_
10	Abbott	abbott	NNP	_	13	nsubj	13:A0
11	will	will	MD	_	13	aux	13:AM-MOD
12	also	also	RB	_	13	advmod	13:AM-DIS
13	take	take	VB	pb=take.01	0	root	_
14	control	control	NN	_	13	dobj	13:A1=PPT
15	of	of	IN	_	14	prep	_
16	7,000	0	CD	_	17	num	_
17	employees	employee	NNS	_	15	pobj	_
18	as	as	RB	_	20	advmod	_
19	well	well	RB	_	20	advmod	_
20	as	as	IN	_	17	cc	_
21	R&D	r&d	NN	p2=NNP	24	nn	_
22	and	and	CC	_	21	cc	_
23	manufacturing	manufacturing	NN	p2=VBG	21	conj	_
24	facilities	facility	NNS	_	17	conj	_
25	in	in	IN	_	13	prep	_
26	several	several	JJ	_	29	amod	_
27	South	south	JJ	_	28	amod	_
28	American	american	JJ	_	29	amod	_
29	countries	country	NNS	_	25	pobj	_
30	.	.	.	_	13	punct	_

